Extended Data Table 2 Data collection and refinement statistics for the BRAFKD–belvarafenib complex
From: ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma

From: ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma